<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24891041</identifier>
<setSpec>1885-1398</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Boteanu, Alina</dc:author>
<dc:author>Guillen Astete, Carlos</dc:author>
<dc:author>Garcia Montes, Nuria</dc:author>
<dc:author>Zea Mendoza, Antonio</dc:author>
<dc:author>Carballo Carmano, César</dc:author>
<dc:author>Medina Quiñones, Carmen</dc:author>
<dc:author>Roldan Moll, Fernando</dc:author>
<dc:description xml:lang="en">The purpose of this study is to determine the rate of bleeding complications in patient's anticoagulated with acenocoumarol according to the international normalized ratio (INR) coagulation index. A cross-sectional study was performed with 901 charts of patients who underwent arthrocentesis or joint infiltration between 2009 and 2013; the charts were grouped on the basis of having an INR higher or lower than 2.0 (268 and 633, respectively). Comparisons were performed in terms of rates of early or late bleeding complications. A 0.37% rate of early bleeding complications (&lt; 24hours) was observed in the group of patients with INR&lt;2 and 0.99% in the group of patients with INR≥2 (P=.47). Only one case of late complication was presented by bleeding between 24 hours and 30 days, in the group of patients with INR≥2. We conclude that oral anticoagulation with acenocoumarol at terapeutical doses does not increase the risk of bleeding joint punctures.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Arthrocentesis</dc:subject>
<dc:subject>Artrocentesis</dc:subject>
<dc:subject>Joint injection</dc:subject>
<dc:subject>Acenocumarol</dc:subject>
<dc:subject>Anticoagulation</dc:subject>
<dc:subject>Infiltración articular</dc:subject>
<dc:subject>Acenocoumarol</dc:subject>
<dc:subject>Anticoagulación</dc:subject>
<dc:date>2015 Jan-Feb </dc:date>
<dc:title xml:lang="en">Is it safe to perform joint infiltrations or aspirations in patients anticoagulated with acenocoumarol?</dc:title>
<dc:publisher>Reumatologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
